AKT1 and neoplasm: Also, salicylate treatment has been suggested to reduce chemotherapy resistance by inhibiting NF-κB activity [225] and it may inhibit Mucin-1 (MUC1)-mediated tumor migration and invasion by inhibiting Akt [226].